CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Operating expenses:
Research and development	$ 63,992	$ 46,024
General and administrative	25,207	21,079
Total operating expenses	89,199	67,103
Loss from operations	(89,199)	(67,103)
Other income (expense), net:
Interest income	9,201	7,037
Other expense, net	(558)	(322)
Total other income, net	8,643	6,715
Net loss	$ (80,556)	$ (60,388)
Net loss per share—basic	$ (2.38)	$ (2.74)
Net loss per share—diluted	$ (2.38)	$ (2.74)
Weighted-average common stock outstanding—basic	33,791,817	22,078,190
Weighted-average common stock outstanding—diluted	33,791,817	22,078,190
Comprehensive loss:
Net Income (Loss)	$ (80,556)	$ (60,388)
Other comprehensive income:
Unrealized gain on available-for-sale investments, net of tax	530	12
Comprehensive loss	$ (80,026)	$ (60,376)